Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-01-29

Clinical Trial Update: Correlation of Serum Gasdermin-D and NLRP-3 Inflammasome Levels With GVHD Biomarkers and Endothelial Damage Markers in Graft-Versus-Host Disease

View source ↗

Summary

A clinical trial investigating correlations between serum biomarkers and GVHD-related endothelial damage has been withdrawn. The study record on ClinicalTrials.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ugur Arzu Kulu | Conditions: Acute Myeloid Leukemia, Adult, Graft Versus Host Disease | Status: WITHDRAWN